|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Real estate, at cost | ||||||||||||||||||||
| Real estate - intangible assets | ||||||||||||||||||||
| Land held for development | ||||||||||||||||||||
| Investments in real estate under construction | ||||||||||||||||||||
| Real estate, gross | ||||||||||||||||||||
| Less: accumulated depreciation and amortization | ||||||||||||||||||||
| Real estate, net | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Right-of-use assets, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Investments in non-consolidated entities | ||||||||||||||||||||
| Deferred expenses, net | ||||||||||||||||||||
| Investment in a sales-type lease, net (allowance for credit loss of $61 in 2023) | ||||||||||||||||||||
| Rent receivable - current | ||||||||||||||||||||
| Rent receivable - deferred | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity: | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Mortgages and notes payable, net | ||||||||||||||||||||
| Revolving credit facility borrowings | ||||||||||||||||||||
| Term loan payable, net | ||||||||||||||||||||
| Senior notes payable, net | ||||||||||||||||||||
| Trust preferred securities, net | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Deferred revenue - including below-market leases, net | ||||||||||||||||||||
| Prepaid rent | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred shares, par value (in dollars per share) | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Series C Cumulative Convertible Preferred, liquidation preference $96,769 and $96,770, respectively; 1,935,375 and 1,935,400 shares issued and outstanding in 2026 and 2025, respectively (cumulative dividends in arrears of $0.8125 per share or $1,573 in the aggregate in 2026) | ||||||||||||||||||||
| Common shares, par value $0.0001 per share; authorized 600,000,000 shares, 58,957,264 and 59,077,234 shares issued and outstanding in 2026 and 2025, respectively | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated distributions in excess of net income | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity |
Loading...
